| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 709520 | Null | 0.0278435641331424 | 0.29584381 |
| NSC 710099 | Null | 0.0278435641331424 | 0.24730599 |
| NSC 717066 | Null | 0.0278435641331424 | 0.26853204 |
| NSC 719661 | 1-O-Octadecyl-[(2.fwdarw.5')-3'-C-ethinyl-cytidylyl]-rac-glycerylyl-(3.fwdarw.5')-5-fluoro-2'-deoxyuridine | 0.0278435641331424 | 0.55408483 |
| NSC 722900 | N-(3-Iodo-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-methylened ioxy-5,11-dioxo-11H-indeno-[1,2-c]isoquinoline | 0.0278435641331424 | 0.432328 |
| NSC 724003 | 5-Chloro-pyrazine-2-carboxylic acid benzylamide | 0.0278435641331424 | 0.054277827 |
| NSC 728087 | Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-ethylamino}propane Bis(trifluoroacetate) | 0.0278435641331424 | 0.49843167 |
| NSC 13713 | Null | 0.0304779558345019 | 0.41429981 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.0304779558345019 | 0.44430141 |
| NSC 287459 | Cytarabine AY | 0.0304779558345019 | 0.58194764 |